| Curis Lifesciences Ltd |
|
Registered Office:
PF-23 GIDC Sanand II,Industrial Estate
,
Ahmedabad
-
382110
,
Gujarat
, India.
Phone :
+91 70965 58558 Fax:
Email : info@curisls.com
Website : https://curisls.com
|
initial public issue of 21,50,000 equity shares of face value of  10/- each of Curis Lifesciences Limited ("Curis" or the "company" or the "Issuer") for cash at a price of 128/- per equity share including a share premium of 118/- per equity share (the "Issue Price") aggregating to 27.52 crores ("the Issue"), of which 1,08,000 equity shares of face value of 10/- each for cash at a price of 128/- per equity share including a share premium of 118/- per equity share aggregating to 1.38 crores will be reserved for subscription by market maker to the issue (the "Market Maker Reservation Portion"). The issue less the market maker reservation portion i.e. net issue of 20,42,000 equity shares of face value of
10/- each at a price of 128/- per equity share including a share premium of 118/- per equity share aggregating to 26.14 crores is herein after referred to as the "Net Issue". The issue and the net issue will constitute 26.59% and 25.26%, respectively, of the post issue paid up equity share capital of the company. |
| Issue |
Money Payable On |
|
| Opens On |
Closes On |
Application |
Allotment |
|
| 07-Nov-25 |
11-Nov-25 |
Rs128.00-0.00 |
Rs0.00-0.00 |
| Minimum Application for shares in Nos :2000 Further Multiples of :1000 |
| |
RsCr |
Lead Managers to the Issue |
|
| Project Cost |
0.00 |
| Finaax Capital Advisors Private Limited |
|
| Project Financed through Current Offer |
27.52 |
|
| Post Issue Equity Share Capital |
8.08 |
|
| Issue Price |
Rs128.00 |
|
|